Abstract
Blood feeding female mosquitoes cause itchy welts and can transmit pathogens that cause diseases such as chikungunya, malaria, West Nile encephalitis, and Zika. Mosquito control programs conduct mosquito, pathogen, and epidemiological surveillance, carry out source reduction, treat mosquito habitats with larvicides or adulticides, and disseminate information to the public. Here, 100 organizations (e.g., private/public mosquito control programs, national professional mosquito/pest control associations) in the United States were asked to complete a survey (N=39 respondents) about their public communication and outreach efforts. Results indicate most programs (N=27, 69%) have dedicated personnel for public communication. A checklist was constructed to compare communication strategies between a subset of program websites and Facebook pages. Recommendations for improving public communication and outreach strategies for mosquito control programs are discussed.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The survey was approved by the East Carolina University Medical Center Institutional Review Board (UMCIRB# 24-000301).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Survey data are provided in the manuscript. More detailed (anonymous) survey data can be requested from the corresponding author.
